Clinical Trial

Dual Mobility Cup Versus Unipolar Cup

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2023 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
The general purpose of this study is to examine whether the dual mobility cup (Novae® Serf) reduces the number of hip dislocations after total hip replacement, both early dislocation (≤1 year) and late dislocation (\>1 year) after primary THR compared with a conventional cup design (Trabecular MetalTM Modular Acetabular System).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-12-22; most recent amendment 2023-03-24.
Trial Details
NCT Number NCT04685239
Lead Sponsor Northern Orthopaedic Division, Denmark
Conditions Dislocation, Hip
Enrollment 1,000 participants
Start Date 2023-04-01
Primary Completion 2025-01 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2023-03-27